These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 3083204
1. The effect of aldose reductase and its inhibition on sugar cataract formation. Kador PF, Akagi Y, Kinoshita JH. Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204 [Abstract] [Full Text] [Related]
4. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors. Kador PF, Akagi Y, Kinoshita JH. Diabet Med; 1985 May 17; 2(3):194-6. PubMed ID: 2952419 [No Abstract] [Full Text] [Related]
5. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts]. Ono H, Nozawa Y, Hayano S. Nippon Ganka Gakkai Zasshi; 1982 May 17; 86(9):1343-50. PubMed ID: 6818854 [No Abstract] [Full Text] [Related]
6. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract. Nozawa H, Yaginuma T, Mizuno A. Nippon Ganka Gakkai Zasshi; 1988 Jan 17; 92(1):194-201. PubMed ID: 3133929 [No Abstract] [Full Text] [Related]
8. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Beyer-Mears A, Cruz E. Diabetes; 1985 Jan 17; 34(1):15-21. PubMed ID: 3917257 [Abstract] [Full Text] [Related]
9. Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications. Beyer TA, Hutson NJ. Metabolism; 1986 Apr 17; 35(4 Suppl 1):1-3. PubMed ID: 3083197 [No Abstract] [Full Text] [Related]
15. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy. Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K. Exp Eye Res; 1987 Jul 17; 45(1):185-6. PubMed ID: 3115805 [No Abstract] [Full Text] [Related]
16. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Jacobson M, Sharma YR, Cotlier E, Hollander JD. Invest Ophthalmol Vis Sci; 1983 Oct 17; 24(10):1426-9. PubMed ID: 6413448 [Abstract] [Full Text] [Related]
17. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Invest Ophthalmol Vis Sci; 1982 Feb 17; 22(2):174-9. PubMed ID: 6799419 [Abstract] [Full Text] [Related]
18. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008]. Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H. Nippon Ganka Gakkai Zasshi; 1987 Feb 17; 91(2):246-53. PubMed ID: 3111200 [No Abstract] [Full Text] [Related]
19. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy. Williams WF, Odom JD. Science; 1986 Jul 11; 233(4760):223-5. PubMed ID: 3088727 [Abstract] [Full Text] [Related]
20. Medical therapy in the prevention of cataract. Brown NA, Bron AJ. Trans Ophthalmol Soc U K (1962); 1985 Jul 11; 104 ( Pt 7)():748-54. PubMed ID: 3938085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]